BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7287865)

  • 1. Assessment of 25-hydroxyvitamin D 1 alpha-hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract.
    Riggs BL; Hamstra A; DeLuca HF
    J Clin Endocrinol Metab; 1981 Oct; 53(4):833-5. PubMed ID: 7287865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology.
    Caniggia A; Lorè F; di Cairano G; Nuti R
    J Steroid Biochem; 1987; 27(4-6):815-24. PubMed ID: 3320561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats.
    Ikeda K; Matsumoto T; Morita K; Yamato H; Takahashi H; Ezawa I; Ogata E
    Endocrinology; 1987 Nov; 121(5):1721-6. PubMed ID: 3311717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
    Lyles KW; Drezner MK
    J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
    Aarskog D; Aksnes L; Markestad T
    Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the hydroxylation of vitamin D in man.
    Loré F; Di Cairano G
    Ann Med Interne (Paris); 1986; 137(3):206-8. PubMed ID: 3767185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 25-hydroxycholecalciferol-1-hydroxylase activity of chick kidney cells: direct effect of parathyroid.
    Bar A; Hurwitz S; Maoz A
    FEBS Lett; 1980 May; 113(2):328-30. PubMed ID: 6248363
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of parathyroid hormone in the regulation of the metabolism of 25-hydroxyvitamin D3.
    Henry HL
    Miner Electrolyte Metab; 1982; 8(3-4):179-87. PubMed ID: 6300629
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal parathyroid hormone-related peptide stimulation of renal 25-hydroxyvitamin D-1-hydroxylase in Hyp mice: evidence for a generalized defect of enzyme activity in the proximal convoluted tubule.
    Nesbitt T; Drezner MK
    Endocrinology; 1990 Aug; 127(2):843-8. PubMed ID: 2373057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.
    Civitelli R; Agnusdei D; Nardi P; Zacchei F; Avioli LV; Gennari C
    Calcif Tissue Int; 1988 Feb; 42(2):77-86. PubMed ID: 3127028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups.
    Zerwekh JE; Sakhaee K; Glass K; Pak CY
    J Clin Endocrinol Metab; 1983 Feb; 56(2):410-3. PubMed ID: 6600460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
    LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
    N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone stimulates mammalian renal 25-hydroxyvitamin D3-1 alpha-hydroxylase in vitro.
    Kremer R; Goltzman D
    Endocrinology; 1982 Jan; 110(1):294-6. PubMed ID: 7053991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroidectomy reduces 25-hydroxyvitamin D3-1 alpha-hydroxylase activity in the hypocalcemic vitamin D-deficient chick.
    Booth BE; Tsai HC; Morris RC
    J Clin Invest; 1977 Dec; 60(6):1314-20. PubMed ID: 915000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells.
    Trechsel U; Bonjour JP; Fleisch H
    J Clin Invest; 1979 Jul; 64(1):206-17. PubMed ID: 109470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of vitamin D on parathyroid function in the elderly.
    Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
    J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D3 formation in women with osteoporosis.
    Silverberg SJ; Shane E; de la Cruz L; Segre GV; Clemens TL; Bilezikian JP
    N Engl J Med; 1989 Feb; 320(5):277-81. PubMed ID: 2911322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase activity by calcium and calcitonin in renal cortex from hypophosphatemic (Hyp) mice.
    Fukase M; Avioli LV; Birge SJ; Chase LR
    Endocrinology; 1984 Apr; 114(4):1203-7. PubMed ID: 6705736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.